ExcellGene SA
We are a Swiss biologics CDMO (contract development and manufacturing organization) specializing in challenging protein expression services and based in Monthey, Switzerland. The heart of ExcellGene is applying smart science and technology to provide high quality proteins. ExcellGene is privately owned, was founded in 2001 by Prof. Dr. Florian M. Wurm and is led by Dr. Maria João Wurm, CEO since 2017. Florian was a manager and scientist at Genentech Inc. and was among the pioneering scientists to generate manufacturing processes for the very first pharmaceutical proteins made in Chinese Hamster Ovary (CHO) cells. We`ve provided biologics and biotech solutions to hundreds of clients, including 6 of the top 10 pharmaceutical firms, biotech companies, contract research organizations and academic institutions.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2001
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
Maria (aka Dr. Maria J. De Jesus) developed several breakthrough technologies as Senior Scientist at the Swiss Federal Institute of Technology (EPFL) in Lausanne. These inventions have had profound effects on cell line development, and some have attained global application in early R&D work towards clinical manufacturing of biologics. Both founders are often invited to speak at conferences on the manufacturing of proteins with recombinant cells in bioreactors.
Starting from work on the very first pharmaceutical proteins made in CHO cells, we've always been driven by science and innovative thinking. As a result, we have unparalleled knowledge on protein expression in bioreactors, and a complete grasp on the control parameters influencing performance in large-scale bioreactors. Our twin expertise in biology and engineering enables us to successfully conclude the most challenging protein expressions and virus vector productions.
Remarkably productive cell hosts.Our transient and stable protein expression technologies and processes are based on proprietary CHOExpress™ cells – a uniquely productive and robust CHO cell host. We see similar performance for HEKExpress™ (HEK cells) and for insect cells (FlyExpress™).
Experts from transfection to manufacturing.We cover the pharmaceutical value chain from DNA construction and transfection to scalable process and manufacture for clinical use.
We serve biotech solutions worldwide
Clients choose us due to our singular scientific expertise from DNA to product and a highly personalized, communicative approach towards each project. Through this, we ensure that your project goals are delivered reliably and in good time.